APLS - Apellis Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APLS is currently covered by 19 analysts with an average price target of $58.23. This is a potential upside of $18.23 (45.58%) from yesterday's end of day stock price of $40.

Apellis Pharmaceuticals's activity chart (see below) currently has 149 price targets and 213 ratings on display. The stock rating distribution of APLS is 73.11% BUY and 26.89% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 72.81% with an average time for these price targets to be met of 214.86 days.

Highest price target for APLS is $106, Lowest price target is $46, average price target is $58.23.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 28-May-2024. First documented stock forecast 04-Dec-2017.

Currently out of the existing stock ratings of APLS, 87 are a BUY (73.11%), 32 are a HOLD (26.89%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

92

$52.47 (132.73%)

92

1 months 17 days ago

3/17 (17.65%)

$51.44 (126.82%)

108

Hold

48

$8.47 (21.43%)

62

1 months 22 days ago

7/8 (87.5%)

$8.32 (20.97%)

65

Buy

60

$20.47 (51.78%)

67

2 months 7 days ago

20/23 (86.96%)

$17.7 (41.84%)

216

Buy

85

$45.47 (115.03%)

85

2 months 7 days ago

10/14 (71.43%)

$42.7 (100.95%)

230

Buy

85

$45.47 (115.03%)

89

2 months 7 days ago

5/7 (71.43%)

$42.7 (100.95%)

391

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?

On average it took 214.86 days on average for the stock forecasts to be realized with a an average price target met ratio 72.81

Which analyst has the current highest performing score on APLS (Apellis Pharmaceuticals) with a proven track record?

STEVEN SEEDHOUSE

Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?

Steven Seedhouse works at RAYMOND JAMES and has 20 price targets and 18 ratings on APLS

Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?

Madhu Kumar with highest potential upside - $101.47

Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?

Dae Gon Ha with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?